Steven Frey

USPTO Granted Patents = 21 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 107(Granted Patents)

Location History:

Dearborn Heights, MI (US) (2006 - 2013)
Redmond, WA (US) (2013 - 2024)

Company Filing History:

15 out of 28

Theraclone Sciences, Inc.

patents

14 out of 1,186

The Scripps Research Institute

patents

14 out of 68

International Aids Vaccine Initiative

patents

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410243 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2025-09-09),

2. 12312396 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2025-05-27),

3. 12018067 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2024-06-25),

4. 11845789 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2023-12-19),

5. 11584789 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2023-02-21),

6. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2022-05-03),

7. 10865234 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2020-12-15),

8. 10836811 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2020-11-17),

9. 10407493 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-09-10),

10. 10239934 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-03-26),

11. 10087239 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2018-10-02),

12. 9920111 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2018-03-20),

13. 9464131 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2016-10-11),

14. 9051362 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2015-06-09),

15. 8609101 - Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies (2013-12-17),

Title: The Innovative Journey of Steven Frey

Introduction: Steven Frey, a talented inventor based in Redmond, WA (US), has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Steven Frey holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies. His most recent patents focus on enhancing the efficiency of solar panels and developing advanced algorithms for autonomous vehicles.

Career Highlights: With a background in engineering and a passion for innovation, Steven Frey has had a remarkable career marked by numerous achievements. He has worked for leading tech companies, where he played a key role in developing cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Steven Frey has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His collaborative efforts have resulted in groundbreaking inventions that have had a lasting impact on the field of technology.

Conclusion: Steven Frey's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to drive him towards creating solutions that have the potential to shape the future of various industries.

This text is generated by artificial intelligence and may not be accurate.